Axatilimab
Phase 1b/2 Study of Axatilimab (SNDX-6352) + Azacitidine (AZA) in Advanced Phase MPN, MPN/MDS Overlap or High-Risk CMML
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1/2
- Enrollment
- 52 patients (estimated)
- Sponsors
- The Ohio State University Comprehensive Cancer Center
- Collaborators
- Incyte Corporation
- Tags
- Monoclonal Antibody, CSF1R Inhibitor
- Trial Type
- Treatment
- Last Update
- SparkCures ID
- 1973
- NCT Identifier
- NCT06523556
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.